ATE534634T1 - 2-phenyl-4-cyclopropyl-pyrimidinderivate - Google Patents

2-phenyl-4-cyclopropyl-pyrimidinderivate

Info

Publication number: ATE534634T1
Authority: AT; Austria
Prior art keywords: cyclopropyl; phenyl; pyrimidine derivatives; pyrimidine; derivatives
Prior art date: 2008-04-11

Application number

AT09730987T

Other languages

English (en)

Inventor

Eva Caroff

Emmanuel Meyer

Original Assignee

Actelion Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-04-11

Filing date

2009-04-09

Publication date

2011-12-15

2009-04-09 Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd

2011-12-15 Application granted granted Critical

2011-12-15 Publication of ATE534634T1 publication Critical patent/ATE534634T1/de

Links

VVSVMCMSJARUID-UHFFFAOYSA-N 4-cyclopropyl-2-phenylpyrimidine Chemical class C1CC1C1=CC=NC(C=2C=CC=CC=2)=N1 VVSVMCMSJARUID-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Diabetes (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT09730987T 2008-04-11 2009-04-09 2-phenyl-4-cyclopropyl-pyrimidinderivate ATE534634T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IB2008051389		2008-04-11
PCT/IB2009/051498 WO2009125365A1 (en)	2008-04-11	2009-04-09	2-phenyl-4-cyclopropyl-pyrimidine derivatives

Publications (1)

Publication Number	Publication Date
ATE534634T1 true ATE534634T1 (de)	2011-12-15

Family

ID=40790423

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT09730987T ATE534634T1 (de)	2008-04-11	2009-04-09	2-phenyl-4-cyclopropyl-pyrimidinderivate

Country Status (17)

Country	Link
US (1)	US8466156B2 (de)
EP (1)	EP2283011B1 (de)
JP (1)	JP5374578B2 (de)
KR (1)	KR101610417B1 (de)
CN (1)	CN101998953B (de)
AR (1)	AR071653A1 (de)
AT (1)	ATE534634T1 (de)
AU (1)	AU2009235123A1 (de)
CA (1)	CA2719569C (de)
ES (1)	ES2376820T3 (de)
IL (1)	IL208548A0 (de)
MA (1)	MA32277B1 (de)
MX (1)	MX2010010932A (de)
NZ (1)	NZ589169A (de)
TW (1)	TW200944516A (de)
WO (1)	WO2009125365A1 (de)
ZA (1)	ZA201008052B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200640877A (en)	2005-04-28	2006-12-01	Actelion Pharmaceuticals Ltd	Pyrimidine derivatives
CL2007002920A1 (es)	2006-10-13	2008-06-06	Actelion Pharmaceuticals Ltd	Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos.
CL2007003038A1 (es)	2006-10-25	2008-06-06	Actelion Pharmaceuticals Ltd	Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos.
EP2225253B1 (de)	2007-11-29	2012-06-27	Actelion Pharmaceuticals Ltd.	Phosphonsäurederivate und ihre verwendung als p2y12-rezeptorantagonisten
AR071652A1 (es)	2008-04-11	2010-07-07	Actelion Pharmaceuticals Ltd	Derivados 2- fenil-piridina substituidos
MA33260B1 (fr)	2009-04-08	2012-05-02	Actelion Pharmaceuticals Ltd	6-(3-azabicyclo[3.1.0.]hex-3-yl)-2-phenylpyrimidines
CA2756654C (en)	2009-04-22	2017-08-22	Actelion Pharmaceuticals Ltd	Thiazole derivatives and their use as p2y12 receptor antagonists
US9539246B2 (en)	2011-08-30	2017-01-10	University Of Utah Research Foundation	Methods and compositions for treating nephrogenic diabetes insipidus
EP3515924B1 (de)	2016-09-22	2021-12-15	Idorsia Pharmaceuticals Ltd	Kristalline formen
MA49887A (fr)	2017-03-15	2020-06-24	Idorsia Pharmaceuticals Ltd	Administration sous-cutanée d'un antagoniste du récepteur p2y12

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2020437A1 (en)	1989-07-05	1991-01-06	Yoshihide Fuse	Cinnamamide derivative
JPH05303586A (ja)	1992-04-07	1993-11-16	Nec Corp	高精度連立一次方程式解析装置
JP2003502314A (ja)	1999-06-14	2003-01-21	イーライ・リリー・アンド・カンパニー	化合物
US6861424B2 (en)	2001-06-06	2005-03-01	Schering Aktiengesellschaft	Platelet adenosine diphosphate receptor antagonists
DE60333866D1 (de)	2002-12-11	2010-09-30	Bayer Schering Pharma Ag	2-aminocarbonlyl-chinolin-verbindungen als adenosin diphosphat plättchenrezeptor antagonisten
ATE481103T1 (de)	2003-04-09	2010-10-15	Wyeth Llc	Derivate von 2-(8,9-dioxo-2,6- diazabicyclo(5.2.0)non-1(7)-en-2- yl)alkylphosphonsäure und deren verwendung als n- methyl-d-aspartat- (nmda-) rezeptorantagonisten
TW200640877A (en)	2005-04-28	2006-12-01	Actelion Pharmaceuticals Ltd	Pyrimidine derivatives
AU2006305538B2 (en)	2005-10-21	2012-06-28	Idorsia Pharmaceuticals Ltd	Piperazine derivatives as antimalarial agents
CL2007002920A1 (es)	2006-10-13	2008-06-06	Actelion Pharmaceuticals Ltd	Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos.
CL2007003038A1 (es)	2006-10-25	2008-06-06	Actelion Pharmaceuticals Ltd	Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos.
MX2009011089A (es)	2007-04-23	2009-10-30	Sanofi Aventis	Derivados de quinolina-carboxamida en calidad de antagonistas de p2y12.
EP2225253B1 (de)	2007-11-29	2012-06-27	Actelion Pharmaceuticals Ltd.	Phosphonsäurederivate und ihre verwendung als p2y12-rezeptorantagonisten
EP2238127B1 (de)	2007-12-26	2012-08-15	Sanofi	Pyrazolcarboxamid-derivate als p2y12-antagonisten
EP2238128B1 (de)	2007-12-26	2012-08-22	Sanofi	Heterocyclische pyrazolcarboxamide als p2y12-antagonisten
AR071652A1 (es)	2008-04-11	2010-07-07	Actelion Pharmaceuticals Ltd	Derivados 2- fenil-piridina substituidos
MA33260B1 (fr)	2009-04-08	2012-05-02	Actelion Pharmaceuticals Ltd	6-(3-azabicyclo[3.1.0.]hex-3-yl)-2-phenylpyrimidines
CA2756654C (en)	2009-04-22	2017-08-22	Actelion Pharmaceuticals Ltd	Thiazole derivatives and their use as p2y12 receptor antagonists

2009
- 2009-04-08 AR ARP090101256A patent/AR071653A1/es unknown
- 2009-04-09 ES ES09730987T patent/ES2376820T3/es active Active
- 2009-04-09 AT AT09730987T patent/ATE534634T1/de active
- 2009-04-09 CN CN200980112591.9A patent/CN101998953B/zh not_active Expired - Fee Related
- 2009-04-09 WO PCT/IB2009/051498 patent/WO2009125365A1/en not_active Ceased
- 2009-04-09 MX MX2010010932A patent/MX2010010932A/es unknown
- 2009-04-09 EP EP09730987A patent/EP2283011B1/de active Active
- 2009-04-09 CA CA2719569A patent/CA2719569C/en active Active
- 2009-04-09 US US12/936,664 patent/US8466156B2/en not_active Expired - Fee Related
- 2009-04-09 JP JP2011503537A patent/JP5374578B2/ja not_active Expired - Fee Related
- 2009-04-09 KR KR1020107024690A patent/KR101610417B1/ko not_active Expired - Fee Related
- 2009-04-09 AU AU2009235123A patent/AU2009235123A1/en not_active Abandoned
- 2009-04-09 NZ NZ589169A patent/NZ589169A/en not_active IP Right Cessation
- 2009-04-10 TW TW098112082A patent/TW200944516A/zh unknown
2010
- 2010-10-07 IL IL208548A patent/IL208548A0/en unknown
- 2010-11-01 MA MA33296A patent/MA32277B1/fr unknown
- 2010-11-10 ZA ZA2010/08052A patent/ZA201008052B/en unknown

Also Published As

Publication number	Publication date
WO2009125365A1 (en)	2009-10-15
CA2719569C (en)	2016-06-07
JP5374578B2 (ja)	2013-12-25
JP2011516539A (ja)	2011-05-26
KR101610417B1 (ko)	2016-04-07
MA32277B1 (fr)	2011-05-02
EP2283011B1 (de)	2011-11-23
TW200944516A (en)	2009-11-01
ES2376820T3 (es)	2012-03-20
IL208548A0 (en)	2010-12-30
CN101998953A (zh)	2011-03-30
US8466156B2 (en)	2013-06-18
AU2009235123A1 (en)	2009-10-15
MX2010010932A (es)	2010-11-05
CN101998953B (zh)	2014-12-17
EP2283011A1 (de)	2011-02-16
NZ589169A (en)	2012-06-29
ZA201008052B (en)	2012-04-25
KR20100132541A (ko)	2010-12-17
CA2719569A1 (en)	2009-10-15
US20110028484A1 (en)	2011-02-03
AR071653A1 (es)	2010-07-07

Publication	Publication Date	Title
DK2308877T3 (da)	2014-04-22	Imidazopyridin-2-on-derivater
DK2164844T3 (da)	2012-08-20	Pyrimidinyl-pyridazinonderivater
DK2209786T3 (da)	2013-06-03	Pyrimidinsubstituerede purinderivater
BRPI0915064A2 (pt)	2015-10-27	derivados de qunoxalinadiona
DE602009000234D1 (de)	2010-11-11	msignals
BRPI0907376A2 (pt)	2015-07-14	Fotobiorretador
EP2376493A4 (de)	2012-05-30	Dihydropyrimidopyrimidinderivat
EP2380877A4 (de)	2012-06-27	Pyridin-3-carbonsäureamidderivat
BRPI0813836A2 (pt)	2015-01-06	Derivados pirazólicos
BRPI0913832A2 (pt)	2015-10-20	derivados de pirrolopiridinilpirimidin-2-ilamina
DE602008003972D1 (de)	2011-01-27	Sitzrücklehnungsmechanismus
DE602008003521D1 (de)	2010-12-30	Sitzrücklehnungsmechanismus
ATE518837T1 (de)	2011-08-15	Indazolamidderivate
DK2275414T3 (da)	2015-06-22	Cyclopentylacrylamidderivat
EP2336132A4 (de)	2012-03-21	Morpholinpurinderivat
DK2152370T3 (da)	2011-08-15	Aryletherpyridazinonderivater
DK2271613T3 (da)	2014-07-14	Hydroxymethylcyklohexylaminer
DE602008003970D1 (de)	2011-01-27	Strahlstromkalibriersystem
ATE545635T1 (de)	2012-03-15	Substituierte n-oxidpyrazinderivate
BRPI0922652A2 (pt)	2015-08-11	Derivados de quinazolinamida
BRPI0913234A2 (pt)	2016-01-19	derivados de tiazolilpiperidina
BRPI0907522A2 (pt)	2019-09-24	biarlamidas
DE112009000183A5 (de)	2011-02-03	Sicherheitsvorreiber
ATE519760T1 (de)	2011-08-15	Isoxazolimidazolderivate
ATE534634T1 (de)	2011-12-15	2-phenyl-4-cyclopropyl-pyrimidinderivate